GlassScriptPhysician profile
William H Long
NPI 1104858489
$484.42
in general payments reported to CMS, 2019-2025
12 companies · $141 in 2025
The $141 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $36.69 · 2021: $61.36 · 2022: $15.50 · 2023: $47.33 · 2024: $183 · 2025: $141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $371.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $370.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $126.28 | 2020-2025 | Jardiance |
| Amgen INC. | $81.27 | 2024-2025 | Repatha, Otezla, Krystexxa |
| Exact Sciences Corporation | $64.25 | 2024-2025 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $36.02 | 2024-2025 | Airsupra |
| Forte Bio-Pharma LLC | $31.44 | 2021-2022 | |
| Pfizer INC. | $29.28 | 2023-2024 | |
| Acadia Pharmaceuticals INC | $28.68 | 2025 | Nuplazid |
| Xeris Pharmaceuticals, INC. | $19.07 | 2023 | Gvoke Hypopen |
| Glaxosmithkline, LLC. | $18.23 | 2024 | Trelegy Ellipta, Arexvy |
| Abbott Laboratories | $17.30 | 2021 | |
| Verity Pharmaceuticals INC. | $17.00 | 2024 | Tlando |
| Novo Nordisk INC | $15.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Long listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.